SPY343.60+0.22 0.06%
DIA282.62-0.33 -0.12%
IXIC11,561.13+44.64 0.39%

JP Morgan Initiates Coverage On Dyne Therapeutics with Overweight Rating, Announces Price Target of $27

JP Morgan analyst Anupam Rama initiates coverage on Dyne Therapeutics (NASDAQ:DYN) with a Overweight rating and announces Price Target of $27.

· 10/12/2020 12:37
JP Morgan analyst Anupam Rama initiates coverage on Dyne Therapeutics (NASDAQ:DYN) with a Overweight rating and announces Price Target of $27.